Nuveen
EPZM

Nuveen’s Epizyme, Inc EPZM Stock Holding History

Nuveen’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-292,102
Closed -$347K – 3605
2022
Q1 		$347K Buy
292,102
+7,244
+3% +$11.8K ﹤0.01% 3094
2021
Q4 		$783K Sell
284,858
-14,034
-5% -$55.1K ﹤0.01% 2940
2021
Q3 		$1.71M Sell
298,892
-15,520
-5% -$94.3K ﹤0.01% 2742
2021
Q2 		$2.61M Sell
314,412
-49,048
-13% -$414K ﹤0.01% 2577
2021
Q1 		$3.17M Sell
363,460
-2,096
-0.6% -$21.7K ﹤0.01% 2395
2020
Q4 		$3.97M Sell
365,556
-39,745
-10% -$490K ﹤0.01% 2188
2020
Q3 		$4.83M Sell
405,301
-47,688
-11% -$639K ﹤0.01% 1930
2020
Q2 		$7.28M Buy
452,989
+75,223
+20% +$1.31M ﹤0.01% 1693
2020
Q1 		$5.86M Buy
377,766
+45,717
+14% +$982K ﹤0.01% 1614
2019
Q4 		$8.17M Buy
332,049
+21,114
+7% +$313K ﹤0.01% 1705
2019
Q3 		$3.21M Sell
310,935
-4,626
-1% -$58.4K ﹤0.01% 2181
2019
Q2 		$3.96M Buy
+315,561
New +$4.06M ﹤0.01% 2107

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuveen's EPZM Position: Q2 2022 in Review

Nuveen sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 292,102 shares — an estimated $347K sold.

Nuveen first reported a position in EPZM in Q2 2019 and held it in 12 quarters. The position peaked at $8.17M in Q4 2019. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Nuveen reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 292,102 Epizyme, Inc shares in Q2 2022, an estimated $347K.
  • Nuveen first reported a position in Epizyme, Inc in Q2 2019 and held it in 12 quarters.
  • Nuveen's Epizyme, Inc position peaked at $8.17M in Q4 2019.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.